Przejdź do zawartości
Merck

Clinical practice: Acute high-altitude illnesses.

The New England journal of medicine (2013-06-14)
Peter Bärtsch, Erik R Swenson
ABSTRAKT

A 45-year-old healthy man wishes to climb Mount Kilimanjaro (5895 m) in a 5-day period, starting at 1800 m. The results of a recent exercise stress test were normal; he runs 10 km 4 or 5 times per week and finished a marathon in less than 4 hours last year. He wants to know how he can prevent becoming ill at high altitude and whether training or sleeping under normobaric hypoxic conditions in the weeks before the ascent would be helpful. What would you advise?

MATERIAŁY
Numer produktu
Marka
Opis produktu

Supelco
Dexamethasone, VETRANAL®, analytical standard
Sigma-Aldrich
Dexamethasone, tested according to Ph. Eur.
Sigma-Aldrich
Dexamethasone, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
Dexamethasone, meets USP testing specifications
Sigma-Aldrich
Dexamethasone, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
Dexamethasone, ≥98% (HPLC), powder
Dexamethasone, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Dexamethasone-Water Soluble, suitable for cell culture, BioReagent
Supelco
Dexamethasone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Acetazolamide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Acetazolamide, ≥99%, powder